Your COVID-19 Treatment Journey: Our Antibodies Might Help
Eli Lilly and Company | February 1, 2021
Much of the dialogue around COVID-19 focuses on awareness of vaccine development and deployment. As the science evolves, this question remains important: What treatment might be appropriate if you test positive for COVID-19?
For high-risk individuals, a positive COVID-19 test doesn’t mean simply staying home in isolation and worrying about whether your illness will get worse. If a high-risk patient tests positive for COVID-19 and has mild-to-moderate symptoms, new monoclonal antibody treatments could provide real help – not just hope.
Fast facts on antibody treatments:
They’re authorized for emergency use by the U.S. Food and Drug Administration (FDA), and they’re available around the country.
Antibody treatments could improve COVID-19 symptoms and make it less likely for high-risk patients to be hospitalized for COVID-19.
Many eligible patients pay no out-of-pocket costs for antibody treatment, although health care institutions may charge a fee for administration of the treatment
These treatments may help alleviate the burden on hospitals by preventing the disease’s progression.
If you test positive for COVID-19, we recommend that you:
Speak with a health care provider about your health situation. Communicate with that HCP to learn about your treatment options. Many people don’t know that they could be eligible for antibody treatments.
Ask if you’re at risk for developing serious COVID-19 symptoms and complications. If you have certain health conditions such as diabetes, obesity, are immunosuppressed, over the age of 55 with heart disease, or over the age of 65, you could be at risk for progressing to severe COVID 19. Antibody treatments are available for patients with mild to moderate COVID-19 with health conditions such as these.
Ask if you might be a candidate for antibody treatments. Your HCP can tell you about the possible benefits and side effects of antibody treatment and help you decide if it may be right for you.
If you’re speaking with an HCP, here’s some know-before-you-go information:
Antibody treatments should be given as soon as possible, and within 10 days of the start of symptoms.
This treatment is administered via a one-time intravenous infusion. It’s usually given at an infusion center, clinic or hospital (but it’s not given to patients admitted to the hospital for COVID-19).
While vaccines may prevent COVID-19, monoclonal antibody treatments could improve COVID-19 symptoms in certain people and help them stay out of the hospital.
You may be able to help your immune system combat COVID-19 with a monoclonal antibody treatment.
More antibody and infusion resources, based on your situation:
To learn more, visit combatcovid.hhs.gov.
If looking for where to find monoclonal antibody treatments to fight COVID-19, visit the National Infusion Center’s COVID-19 website or the U.S. Health & Human Services therapeutics distribution website.
If your health networks or hospital system is looking for guidance on establishing infusion units to treat patients with COVID-19 in diverse settings, read Lilly's operations guide about infusion units for COVID-19 antibody treatment and COVID antibody infusion clinic learnings.
We’re seeking to help prevent COVID-19 hospitalizations by ensuring you and your loved ones have the information needed to seek treatment if or when diagnosed with COVID-19.